News

The TMIOA Medical Director highlights the best sessions, new topics, and growing discussion around the 18th annual congress.

The drug is indicated in capsule form for adults and in a liquid formulation for children.

2020 was the year when regulators, clinicians, and patients had no choice but to embrace the concept of wearable monitoring devices. But it’s been a long time coming for the technology class.

Pediatric patients who initiated insulin pump therapy within 6 months of diagnosis demonstrated better cardiovascular risk profiles than those who delayed treatment.

Repeated Transcranial Magnetic Stimulation shows more efficacy treating bipolar disorder than schizophrenia.

If approved, the vaccine may become available to the US public as early as December 21st.

In a poster presented at ACG, investigators find a new patch test could help patients who are not responding to PPI therapy.

New data shows a large shift from mortality due bacterial infection to other sickle cell disease causes, treatment complications, or non-related comorbidities.

The approval represents the first ever therapy for chronic weight management for obesity caused by a trio of genetic deficiencies.

Inflammatory bowel disease patients were surveyed about their remission or flare-up status, as well as their expectations for a flare-up over the next 2 months.

The risk of suicidality and psychological adverse events appears to be particularly high in younger men with alopecia who are given finasteride.

The first case report of COVID-19 reinfection in a patient with beta thalassemia major describes absence of symptoms and two-month interval between positive PCR tests.

Patients with late-onset asthma and allergies had an increased risk of COPD as well as a heightened risk of landing in the “multiple disorders” comorbidity profile.

Liquidia Technologies plans on addressing FDA concerns regarding treprostinil.

Patients with hematological disorders like sickle cell disease or β-thalassemia are at high risk for HCV infection as a result of frequent transfusions.

Literature is scarce in identifying and characterizing risk of post-operative diabetes mellitus among patients with pancreatic cystic lesions.

Dr. Tobias Moeller-Bertram discusses how alternative therapies could replace opioids in the future for chronic pain.

More studies are planned testing the impact of finerenone.

Finerenone could be another option to SGLT2 inhibitors for this patient population.

About 20% of 81 positive patients experienced critical neurological complications; further, half had a pre-existing history of high blood pressure or type 2 diabetes.

Guidance based on procalcitonin concentration levels may useful in reducing duration of antibiotic treatment for sickle cell patients with acute chest syndrome.

Researchers present new data from the SUSTAIN 6 and PIONEER 6 trials during the virtual AHA 2020 conference.

The indication comes from collaborative work among experts and community leaders coordinated by the Oxalosis & Hyperoxaluria Foundation and the Kidney Health Initiative.

To date, 3 vaccine candidates with favorable safety profiles show promise in offering protection against COVID-19.

The rates of ALT normalization maintained in both arms of the 96 week study.

The newest indication coincides with growing concerns that COVID-19 and flu spread will cause unprecedented burden on the US this winter.

The lipid profile changes were not significant after 6 months, while the changes in the lipid profile are due to other factors and not the drugs.

The AI-based technology is expected to augment telehealth and remote services for a vast majority of cardiological cases.